Biochemical control and toxicity after intensity-modulated radiation therapy for prostate cancer

Technology in Cancer Research and Treatment

Volumn 8, Issue 3, 2009, Pages 201-206

  Liauw, Stanley L ^a   Weichselbaum, Ralph R ^a   Rash, Carla ^a   Correa, David ^a   Al Hallaq, Hania A ^a   Pelizzari, Charles A ^a   Jani, Ashesh B ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Intensity modulated RT (IMRT); Outcomes; Prostate cancer; Radiation therapy (RT)

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; DIGESTIVE SYSTEM INJURY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROSTATE CANCER; RADIATION DOSE; RADIATION INJURY; RECTUM; RISK ASSESSMENT; UROGENITAL TRACT DISEASE;

EID: 66049106353     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460900800304     Document Type: Article

References (19)

1. Kupelian, P. A., Elshaikh, M., Reddy, C. A., et al. Comparison of the Efficacy of Local Therapies for Localized Prostate Cancer in the Prostate-Specific Antigen Era: A Large Single-Institution Experience with Radical Prostatectomy and External-Beam Radiotherapy. J Clin Oncol 20, 3376-3385 (2002).
2. Potters, L., Klein, E. A., Kattan, M. W., et al. Monotherapy for Stage T1-T2 Prostate Cancer: Radical Prostatectomy, External Beam Radiotherapy, or Permanent Seed Implantation. Radiother Oncol 71, 29-33 (2004). (Pubitemid 38452899)
3. Cahlon, O., Zelefsky, M. J., Shippy, A., et al. Ultra-High Dose (86.4 Gy) IMRT for Localized Prostate Cancer: Toxicity and Biochemical Outcomes. Int J Radiat Oncol Biol Phys 71, 330-337 (2008).
4. De Meerleer, G. O., Fonteyne, V. H., Vakaet, L., et al. Intensity-modulated radiation therapy for prostate cancer: late morbidity and results on biochemical control. Radiother Oncol 82, 160-166 (2007). (Pubitemid 46298776)
5. Eade, T. N., Horwitz, E. M., Ruth, K., et al. A Comparison of Acute and Chronic Toxicity for Men with Low-Risk Prostate Cancer Treated with Intensity-Modulated Radiation Therapy or (125)I Permanent Implant. Int J Radiat Oncol Biol Phys 71, 338-345 (2008).
6. Kupelian, P. A., Willoughby, T. R., Reddy, C. A., et al. Hypofractionated Intensity-Modulated Radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience. Int J Radiat Oncol Biol Phys 68, 1424-1430 (2007).
7. Martin, J. M., Rosewall, T., Bayley, A., et al. Phase II Trial of Hypofractionated Image-Guided Intensity-Modulated Radiotherapy for Localized Prostate Adenocarcinoma. Int J Radiat Oncol Biol Phys 69, 1084-1089 (2007). (Pubitemid 47625844)
8. Zelefsky, M. J., Chan, H., Hunt, M., et al. Long-term Outcome of High Dose Intensity Modulated Radiation Therapy for Patients with Clinically Localized Prostate Cancer. J Urol 176, 1415-1419 (2006). (Pubitemid 44307191)
9. Roach, M. 3rd, Hanks, G., Thames, H., Jr., et al. Defining Biochemical Failure Following Radiotherapy With or Without Hormonal Therapy in Men with Clinically Localized Prostate Cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65, 965-974 (2006). (Pubitemid 43914244)
10. Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys 37, 1035-1041 (1997).
11. Williams, S. G., Pickles, T., Kestin, L., et al. A Multicenter Study Demonstrating Discordant Results from Electronic Prostate-Specific Antigen Biochemical Failure Calculation Systems. Int J Radiat Oncol Biol Phys 65, 1494-1500 (2006). (Pubitemid 44425207)
12. Dearnaley, D. P., Sydes, M. R., Graham, J. D., et al. Escalated-Dose Versus Standard-Dose Conformal Radiotherapy in Prostate Cancer: First Results from the MRC RT01 Randomised Controlled Trial. Lancet Oncol 8, 475-487 (2007).
13. Kuban, D. A., Tucker, S. L., Dong, L., et al. Long-term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer. Int J Radiat Oncol Biol Phys 70, 67-74 (2008). (Pubitemid 350251041)
14. Peeters, S. T., Heemsbergen, W. D., Koper, P. C., et al. Dose-Response in Radiotherapy for Localized Prostate Cancer: Results of the Dutch Multicenter Randomized Phase III trial Comparing 68 Gy of Radiotherapy with 78 Gy. J Clin Oncol 24, 1990-1996 (2006).
15. Zietman, A. L., DeSilvio, M. L., Slater, J. D., et al. Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the Prostate: A Randomized Controlled Trial. JAMA 294, 1233-1239 (2005).
16. Pollack, A., Zagars, G. K., Starkschall, G., et al. Prostate Cancer Radiation Dose Response: Results of the M. D. Anderson Phase III Randomized Trial. Int J Radiat Oncol Biol Phys 53, 1097-1105 (2002).
17. Zelefsky, M. J., Fuks, Z., Hunt, M., et al. High Dose Radiation Delivered by Intensity Modulated Conformal Radiotherapy Improves the Outcome of Localized Prostate Cancer. J Urol 166, 876-881 (2001). (Pubitemid 32750970)
18. D'Amico, A. V., Manola, J., Loffredo, M., et al. 6-month Androgen Suppression plus Radiation Therapy vs Radiation Therapy Aone for Patients with Clinically Localized Prostate Cancer: A Randomized Controlled Trial. JAMA 292, 821-827 (2004). (Pubitemid 39079668)
19. Thames, H., Kuban, D., Levy, L., et al. Comparison of Alternative Biochemical Failure Definitions Based on Clinical Outcome in 4839 Prostate Cancer Patients Treated by External Beam Radiotherapy Between 1986 and 1995. Int J Radiat Oncol Biol Phys 57, 929-943 (2003). (Pubitemid 37324110)